From the original source:
TechCrunch — AI
Read full article at TechCrunch — AIThis material was compiled from public sources. If its publication affects your rights → Request removal
Enveda secures $311M to bring more nature-derived AI drugs into clinical trials
The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.
AI Summary & Key Takeaways
- The round valued the AI biotech at $2 billion
- It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.
Enveda secures $311M to bring more nature-derived AI drugs into clinical trials
Related stories
Co-founder of Replika launched Wabi - an AI messenger that creates applications itself
🤖 The co-founder of Replika launched Wabi - an AI messenger that creates applications itself. Evgenia Kuida opened access to Wabi - a personal AI agent that combines a messenger and a mini-application generator. Instead of the usual chats, here you can create separate threads for different...
Anthropic pitches AI safety bill that may block a model if 50+ people could be killed
The proposed policy seems to offer protections against AI run amok but actually forbids federal agencies from blocking a model's release without the permission of a judge.
Hugging Face CEO warns that Netflix’s OpenAI hack documentary isn’t accurate
Before you share the Netflix documentary "AI Gone Rogue" take note. Clem Delangue, Hugging Face's co-founder who is featured in the film, says it went "full doomer mode" and isn't accurate.
SpaceX's AI business exceeds investor expectations
SpaceX Reports AI Profit Growth, Beating Expectations.